The tingling and burning start in your feet. Sometimes your feet feel numb, so it feels like you’re walking on foam. Sometimes they are numb during the day and then painful at night, so you can’t even put a sheet on over your feet.
This is diabetic neuropathy. It affects up to 60% of people with type 2 diabetes, and it’s one of the most debilitating complications of the disease.
The drugs prescribed for it, like gabapentin, pregabalin, and duloxetine, work for some people, some of the time, but they have significant side effects, and they don’t do anything to address the underlying damage. They just make it hurt a little less.
What about natural nerve pain relief? Is there something natural that can help, that has fewer side effects? Or that has side benefits?
In this article, we’ll look at what the research actually shows about natural approaches to nerve pain relief. So let’s dig in.
What’s Actually Happening to Your Nerves
Before we look at natural approaches to pain relief, we need a better understanding of what’s actually happening at the cellular level. When blood glucose remains elevated over time, it damages peripheral nerves. First, excess glucose enters the sorbitol pathway, producing compounds that deplete antioxidants and promote oxidative stress within nerve cells. This causes the myelin sheath, the protective coating around the nerve fibers, to become thinner and degrade.
You end up with reduced blood flow to the nerves, and the nerves literally begin to starve for oxygen and nutrients. At first, the small fibers are affected, causing burning and tingling, and later the large fibers, which affect your reflexes and balance. This is why so many people with diabetic neuropathy experience burning and hypersensitivity early, and later on develop numbness and balance problems. The damage is progressing from small nerve fibers to larger nerve fibers.
The good news is that these pathways can be addressed. Several natural interventions target these pathways directly, and the evidence is probably stronger than most people realize.
1. A Whole-Foods Plant-Based Diet: A Solid Foundation for Reversing Diabetes
Now, you may not want to hear this, but we need to talk about diet first. Because there isn’t a supplement in the whole world that fully compensates for a diet that continues to damage your nerves every day.
If your kitchen sink was plugged up, and the faucet was running so that the water was flowing over onto the kitchen floor, it wouldn’t make sense just to keep mopping up the floor, would it? It would make sense to turn off the water, stop the inflow, and then unplug the drain so that the water would go down the drain where it belongs. Then cleaning up the kitchen floor would be a very simple task that you would only have to do once.
This is true of type 2 diabetes as well. We don’t want to just mop up the mess of diabetic neuropathy. We want to stop the incoming excess high blood glucose levels at the root cause, so that your body can get back to metabolic health.
This isn’t just a pipe dream. This is the outcome you should aim for.
Diabetes reversal has been proven enough times now in clinical trials that the American Diabetes Association formally recognizes type 2 diabetes remission as a legitimate and worthy clinical target. In other words, diabetes reversal is going mainstream.
Behind the scenes of this “Push for Type 2 Diabetes Remission” is the work by Roy Taylor at Newcastle University. He spent many years demonstrating that sufficient weight loss can return fasting blood sugar and HbA1c to normal levels in people with type 2 diabetes without medication. Even in people who are not overtly overweight or obese, if they lost sufficient weight to reduce excess liver and pancreas fat, they too could experience diabetic remission.
There are quite a few different ways to lose weight, but a whole food plant-based diet is one of the most effective paths to long-term weight loss. The evidence on that specifically for diabetic neuropathy comes from a randomized controlled trial by Anne Bunner, Neal Barnard, and colleagues at the Physicians Committee for Responsible Medicine in Washington, D.C. Their 20-week pilot study, published in Nutrition and Diabetes in 2015, randomized 35 adults with type 2 diabetes and painful diabetic neuropathy to either a low-fat plant-based diet with weekly nutrition support classes, or a control group receiving only a B12 supplement. (DOI: 10.1038/nutd.2015.8)
While the people on the whole foods plant-based diet did not completely reverse their type 2 diabetes (because this wasn’t the goal), they still got great results for their diabetic neuropathy. Pain measured by the Short Form McGill Pain Questionnaire declined by 9.1 points in the diet group, compared with just 0.9 points in the control group (p=0.04). The Michigan Neuropathy Screening Instrument questionnaire score improved significantly more in the diet group (p=0.03). Body weight dropped an average of 7 kilograms in the diet group versus 0.6 kilograms in the control group. And foot electrochemical skin conductance, a measure of sudomotor nerve function, stayed stable in the diet group while it declined in controls (p=0.03), suggesting the diet may have halted active nerve function loss.
Barnard’s team was testing for relief of diabetic neuropathy. But the deeper story in that weight loss number is about what becomes possible when you keep going. Seven kilograms in 20 weeks. Keep that trajectory going with a truly committed plant-based diet, and you’re in the territory where diabetes remission becomes achievable for many people. Roy Taylor found that often 30 to 35 pounds of weight loss was necessary to reverse diabetes. So these people were on the right track.
You can take supplements, and they have real value. But they work much better if you get the foundation right first, or at the same time. And if you’ve had diabetes for less than 10 years, your chances of completely reversing your diabetes are very good.
2. Alpha-Lipoic Acid: The Most Studied Supplement for Nerve Pain
Alpha-lipoic acid (ALA) is a potent antioxidant that is both fat-soluble and water-soluble, which means it can reach and protect nerve tissue in ways that most antioxidants can’t. It also helps recycle vitamins C and E, amplifying their effects.
There’s more evidence for the benefits of ALA than any other supplement for diabetic neuropathy. Dan Ziegler and colleagues at the German Diabetes Research Institute in Düsseldorf have been studying ALA in diabetic neuropathy for over 25 years, running a series of trials known collectively as the ALADIN, SYDNEY, and NATHAN studies.
The landmark oral trial is the SYDNEY 2 study, published in Diabetes Care in 2006. Ziegler and his colleagues, including Peter Dyck at Mayo Clinic and Itamar Raz in Israel, randomized 181 diabetic patients with distal symmetric polyneuropathy to oral ALA at 600 mg, 1,200 mg, or 1,800 mg per day, or placebo, for 5 weeks. (DOI: 10.2337/dc06-1216)
The Total Symptom Score (burning pain, stabbing pain, paresthesia, and asleep numbness in the feet) dropped by 51% in the 600 mg group versus 32% in placebo. The response rate, defined as at least a 50% reduction in symptoms, was 62% in the 600 mg group compared with 26% in placebo. The 600 mg dose also had the best risk-to-benefit profile: higher doses produced more nausea without proportionally better results.
A more recent randomized double-blind trial by Mamdouh El-Nahas and colleagues at Mansoura University in Egypt, published in 2020, tested oral ALA at 600 mg twice daily (1,200 mg/day) in 200 patients for 6 months. Significant improvements were seen in pain scores, vibration perception threshold, and neurological disability scores compared with placebo — and the treatment was well tolerated throughout. (DOI: 10.2174/1871530320666200506081407)
So it looks like 600 milligrams a day, or maybe 600 milligrams twice a day, works well for ALA.
3. Benfotiamine: The B1 Derivative That Targets the Root Cause
Benfotiamine is a fat-soluble form of vitamin B1 (thiamine), and it works through a different mechanism than ALA. Rather than simply neutralizing oxidative damage after it occurs, benfotiamine activates an enzyme called transketolase that redirects excess glucose metabolites away from the toxic pathways that damage nerve cells. It addresses the cause at the biochemical level, not just the downstream effects.
The BENDIP trial, led by Hilmar Stracke and colleagues at the University Hospital Giessen in Germany, published in Experimental and Clinical Endocrinology and Diabetes in 2008, was the largest RCT of benfotiamine in diabetic neuropathy. 165 patients were randomized to 600 mg per day, 300 mg per day, or placebo for 6 weeks. The 600 mg group showed significant improvement in the Neuropathy Symptom Score versus placebo (p=0.033 in per-protocol analysis), with the best results for pain specifically. The higher dose and longer treatment duration both produced better outcomes. (DOI: 10.1055/s-2008-1065351)
An earlier pilot study, the BEDIP trial, by Haupt, Ledermann, and Köpcke, published in the International Journal of Clinical Pharmacology and Therapeutics in 2005, found significant improvement in neuropathy score and pain with 400 mg per day over 3 weeks in 40 inpatients, and was described as confirming the results of two previous RCTs. (DOI: 10.5414/cpp43071)
Benfotiamine and ALA work on different targets and are often used together. There is no known interaction between them. It would make sense to use both of these simultaneously for an additive effect. But I haven’t found any clinical trials that use both of them together.
4. Acetyl-L-Carnitine: Real Results, With a Caveat
Acetyl-L-carnitine (ALC) plays a role in mitochondrial energy production and has neuroprotective and neurotrophic effects in peripheral nerve tissue. It has been studied for diabetic neuropathy in several randomized trials.
The strongest individual trial is the 12-month multicenter study by Domenico De Grandis and Chiara Minardi at the Ospedale Civile in Rovigo, Italy, published in Drugs in R&D in 2002. 333 patients with diabetic neuropathy were randomized to ALC or placebo for one year. At 12 months, nerve conduction velocity improved significantly in the ALC group, and mean pain scores dropped 39% from baseline in the ALC-treated patients, compared with just 8% in placebo. (DOI: 10.2165/00126839-200203040-00001)
That’s a compelling individual trial result. But not all of the trials have had such promising results. The 2019 Cochrane systematic review of ALC for diabetic neuropathy, which included 4 trials with 907 participants, rated the overall evidence as very low certainty due to inconsistency across trials and risk of bias. (DOI: 10.1002/14651858.CD011265.pub2) The 2023 systematic review by Jennifer Frediani and colleagues at Emory University, published in Pain Practice, did ultimately conclude that the review “supports the use of alpha-lipoic acid, acetyl-l-carnitine, and vitamin D” specifically for diabetic peripheral neuropathy. (DOI: 10.1111/papr.13291)
ALC is reasonable to include, particularly at doses above 1,500 mg per day where the evidence is stronger. But it’s third on the list behind ALA and benfotiamine for a reason.
5. Vitamin D: The Deficiency Nobody’s Checking For
This one is short but important. Vitamin D deficiency is extremely common in people with type 2 diabetes, and low vitamin D levels have been consistently associated with worse neuropathy outcomes. A 2022 narrative review by Domenico Plantone and colleagues at the University of Siena, published in the International Journal of Molecular Sciences, identified vitamin D deficiency as a risk factor for diabetic neuropathy alongside several other neurological diseases. (DOI: 10.3390/ijms24010087)
The Frediani et al. review also specifically supports vitamin D for DPN. Low-dose supplementation hasn’t moved the needle much in trials, which suggests that achieving adequate levels — not just avoiding outright deficiency — is what matters.
If you haven’t had your vitamin D level checked recently, get it checked.. Supplementation is almost always needed unless you spend a significant amount of your daylight hours outside in the sunshine. The target range for 25(OH)D is 50 to 80 ng/ml.
6. BioActive Vitamin B Complex: More Than Just B12
B12 gets most of the attention in diabetic neuropathy, and rightly so. It is essential for myelin sheath integrity, and B12 deficiency, which is especially common in people taking metformin (metformin blocks B12 absorption over time), produces neuropathy that is clinically indistinguishable from diabetic nerve damage. If you’re on metformin and haven’t had your B12 checked recently, do it.
But B12 is not the only B vitamin that matters here.
Pyridoxal-5-phosphate (P5P) is the bioactive, activated form of vitamin B6, and it plays a role in diabetic neuropathy that most practitioners overlook. P5P functions as an antioxidant as well as a coenzyme, and one of its documented mechanisms is trapping methylglyoxal and other dicarbonyl compounds that accumulate in diabetes and drive the formation of advanced glycation end products (AGEs). AGEs are among the primary drivers of nerve damage in diabetic neuropathy. P5P intercepts them at the chemical level.
A 2023 cross-sectional study published in the Saudi Pharmaceutical Journal by Kesavan, Kiruba, Vaishnavi, and colleagues examined 249 diabetic neuropathy patients and found that 51.8% had pyridoxine deficiency, while only 19.3% had sufficient B6 levels. Nerve conduction velocity showed a strong direct correlation with pyridoxine levels: the lower the B6, the slower the nerve signal. (DOI: 10.1016/j.jsps.2023.03.005)
That’s more than half of diabetic neuropathy patients walking around with a deficiency in a nutrient that directly correlates with their nerve function. It’s not being screened for. It’s not being replaced.
The case for combining these bioactive B forms comes from a clinical trial by Mackie Walker, Lauren Morris, and Dunlei Cheng at the Carolina Musculoskeletal Institute, published in Reviews in Neurological Diseases in 2010. Twenty type 2 diabetic patients with neuropathy were given a combination of L-methylfolate (3 mg), methylcobalamin (2 mg), and pyridoxal-5-phosphate (35 mg) twice daily for 4 weeks, then once daily for 48 more weeks. Statistically significant improvements in one-point (tactile) and two-point (discriminatory) static sensation testing were observed at the great toe and heel at 6 months, at 1 year, and in the interval between them. The greatest improvement came between baseline and 1 year. (PubMed: 21206429)
One-point and two-point discrimination are measures of actual nerve fiber restoration, not just symptom suppression. This was not an overnight process, as the greatest improvement came a year later in this trial. It pays to stick with it and be patient. Bioactive B vitamins actually help rebuild nerves and prevent further damage.
It is important to use the bioactive forms of these B vitamins: P5P instead of standard B6, methylcobalamin rather than cyanocobalamin, and L-methylfolate instead of folic acid. Some people do not convert these inactive forms very well. If your nervous system is already metabolically stressed, it seems the bioactive forms perform better. Our Hallelujah Diet B12 has active forms of all three of these B vitamins: P5P, L-methylfolate, and methylcobalamin.
A Hallelujah Diet Perspective
God designed our bodies with self-healing built in. Genesis 1:29 points us towards God’s original diet for us: fruits, vegetables, nuts, seeds, and plants in general. Our bodies were originally designed to run on plants. And we find, when we get close to that again (trying to take into account the differences in our environment and the Garden of Eden), we find that health and self-healing work better.
Most articles on diabetic neuropathy just talk about managing symptoms and which drug or supplement works better. But the possibilities are much better than that.
As I mentioned above, the research by Roy Taylor at Newcastle University demonstrates that you can really eliminate diabetic neuropathy by reversing your type 2 diabetes completely. You can restore the function of your liver and pancreas just by losing enough body weight to clear out the excess fat from these organs. Your liver will become insulin sensitive again, and your beta cells will work again.
Why keep mopping up the floor when you could turn off the faucet? You wouldn’t do that in the kitchen, and you shouldn’t do that with your health either.
The Hallelujah Diet is one of the most effective tools for weight loss and improving your metabolism. This will make diabetic remission possible. We have a lot of great recipes on our website, and it doesn’t require suffering and misery. You just substitute whole foods for the recipes and ingredients you already like. You can eat real food, whole foods like fruits, vegetables, whole grains, legumes, nuts, and seeds, all made in a way you enjoy. You can eat gourmet foods or really simple foods. There are lots of ways to do this. Not sure where to start? Check out our “Get Started” page.
We’ve seen many people transform their metabolic health and regain their health using the Hallelujah Diet, with many of their stories in our testimonies database.
If you want faster results and you want to get rid of your diabetic neuropathy as quickly as possible, the supplement stack makes sense.
Using Alpha Lipoic Acid at 600 mg a day would be a good start. Then adding Benfotiamine also, as it works in a different pathway. Taking a daily Hallelujah Diet B12 that includes all three active forms of B6, folate, and B12 will help restore nerve function and structure.
Making sure you’re not vitamin D deficient just makes sense for diabetes and every other health condition you might be suffering from. While you’re at it, you should take some fish oil, as it helps reduce systemic inflammation.
Hope: Oxygen for the Soul
What I want you to take away from this article is hope. You’re not stuck and you don’t have to just manage your symptoms. You can change the trajectory of your health starting today.
Like George Malkmus used to say, “If you keep doing what you’ve always done, you’re going to get what you’ve always got.” So you have to change your programming and renew your mind. Start with hope. Even though you’ve always thought you were stuck with type 2 diabetes, the truth is that many people have already reversed their type 2 diabetes. So, why not you?
Change your thoughts, which will change your beliefs, which will lead to better actions and better habits. Better habits will change your health, day by day, and you’ll have a new health destiny. And that will give you a reason to shout, “Hallelujah!”
References
- Bunner AE, Wells CL, Gonzales J, Agarwal U, Bayat E, Barnard ND. “A dietary intervention for chronic diabetic neuropathy pain: a randomized controlled pilot study.” Nutrition and Diabetes. 2015;5:e158. https://doi.org/10.1038/nutd.2015.8
- Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. “Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.” Diabetes Care. 2006;29(11):2365–2370. https://doi.org/10.2337/dc06-1216
- El-Nahas MR, Elkannishy G, Abdelhafez H, Elkhamisy ET, El-Sehrawy AA. “Oral alpha lipoic acid treatment for symptomatic diabetic peripheral neuropathy: a randomized double-blinded placebo-controlled study.” Endocrine, Metabolic & Immune Disorders Drug Targets. 2020;20(9):1531–1534. https://doi.org/10.2174/1871530320666200506081407
- Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG. “Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.” Experimental and Clinical Endocrinology and Diabetes. 2008;116(10):600–605. https://doi.org/10.1055/s-2008-1065351
- Haupt E, Ledermann H, Köpcke W. “Benfotiamine in the treatment of diabetic polyneuropathy — a three-week randomized, controlled pilot study (BEDIP study).” International Journal of Clinical Pharmacology and Therapeutics. 2005;43(2):71–77. https://doi.org/10.5414/cpp43071
- De Grandis D, Minardi C. “Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study.” Drugs in R&D. 2002;3(4):223–231. https://doi.org/10.2165/00126839-200203040-00001
- Rolim LC, da Silva EM, Flumignan RL, Abreu MM, Dib SA. “Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.” Cochrane Database of Systematic Reviews. 2019;6:CD011265. https://doi.org/10.1002/14651858.CD011265.pub2
- Frediani JK, Lal AA, Kim E, Leslie SL, Boorman DW, Singh V. “The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: a systematic review.” Pain Practice. 2024;24(1):186–210. https://doi.org/10.1111/papr.13291
- Plantone D, Primiano G, Manco C, Locci S, Servidei S, De Stefano N. “Vitamin D in neurological diseases.” International Journal of Molecular Sciences. 2022;24(1):87. https://doi.org/10.3390/ijms24010087
- Walker MJ, Morris LM, Cheng D. “Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5′-phosphate.” Reviews in Neurological Diseases. 2010;7(4):132–139. https://pubmed.ncbi.nlm.nih.gov/21206429/
- Kesavan M, Kiruba GK, Vaishnavi R, et al. “Impact of vitamin B6 deficiency on the severity of diabetic peripheral neuropathy: a cross-sectional study.” Saudi Pharmaceutical Journal. 2023;31(6):793–799. https://doi.org/10.1016/j.jsps.2023.03.005
- Lutz R. “Nutritional management of diabetic neuropathy: a clinical approach.” Today’s Practitioner. 2025. https://todayspractitioner.com/diabetes/nutritional-management-of-diabetic-neuropathy-a-clinical-perspective/
